Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DN3IG4
|
|||
| Drug Name |
V181
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Dengue fever [ICD-11: 1D2Z; ICD-10: A97, A97.9; ICD-9: 61] | Phase 2 | [1] | |
| Company |
Merck
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05507450) A Phase 2, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Immunogenicity of Three Different Potency Levels of V181 (Dengue Quadrivalent Vaccine rDENVdelta30 [Live, Attenuated]) in Healthy Adults. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.